glp 1 effects GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Q&A: Long-term success of GLP-1

NEUPRO may not be right for you

On Thursday, the Trump Administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs for people enrolled in Medicare and Medicaid, as well as for cash buyers

It is not a price cut

This duality underscores the therapeutic potential of targeting microbiotaGLP-1 interactions in metabolic disorders

readers should verify current information directly with relevant platforms, manufacturers, and healthcare providers

doi: 10.3389/fddsv.2026.1792418 Received 20 January 2026 Revised 11 March 2026 Accepted 16 March 2026 Published 10 April 2026 Volume 6 - 2026 Edited by Liang Xu, University of Kansas, United States Reviewed by Christel Menet, Confo Therapeutics, Belgium Anukriti Saran, Banasthali University, India Updates Copyright 2026 Niazi